Group One Trading’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,900
Closed -$1.7K 8388
2025
Q3
$1.7K Sell
8,900
-141,100
-94% -$169K ﹤0.01% 7944
2025
Q2
$255K Buy
+150,000
New +$253K ﹤0.01% 4096
2025
Q1
Sell
-15,900
Closed -$28.5K 7793
2024
Q4
$28.5K Hold
15,900
﹤0.01% 5471
2024
Q3
$96.4K Buy
+15,900
New +$87.4K ﹤0.01% 4212
2024
Q1
Sell
-3,200
Closed -$21.1K 7262
2023
Q4
$21.1K Buy
+3,200
New +$15.8K ﹤0.01% 5713
2023
Q3
Sell
-2,100
Closed -$5.67K 7798
2023
Q2
$5.67K Buy
+2,100
New +$6.16K ﹤0.01% 6671

Group One Trading's EPIX Position: Q3 2025 in Review

Group One Trading sold out of ESSA Pharma (EPIX) in Q3 2025, closing a stake of 83,823 shares — an estimated $100K sold.

Group One Trading first reported a position in EPIX in Q4 2022 and held it in 8 quarters. The position peaked at $168K in Q3 2024. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2025.

  • Group One Trading reported no remaining ESSA Pharma position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 83,823 ESSA Pharma shares in Q3 2025, an estimated $100K.
  • Group One Trading first reported a position in ESSA Pharma in Q4 2022 and held it in 8 quarters.
  • Group One Trading's ESSA Pharma position peaked at $168K in Q3 2024.
  • 32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.